|
[1]
|
Kang M, Yi Y, Li Y, Sun LM, Deng AP, Hu T, et al. Effectiveness of inactivated COVID-19 vaccines against COVID-19 pneumonia and severe illness caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in Guangdong, China. http://dx.doi.org/10.2139/ssrn.3895639. [2021-8-5].http://dx.doi.org/10.2139/ssrn.3895639 |
|
[2]
|
World Health Organization. Tracking SARS-CoV-2 variants. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. [2021-8-12].https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ |
|
[3]
|
Liu FF, Zheng CJ, Wang LP, Geng MJ, Chen H, Zhou S, et al. Interpretation of the protocol for prevention and control of COVID-19 in China (Edition 8). China CDC Wkly 2021;3(25):527 − 30. http://dx.doi.org/10.46234/ccdcw2021.138CrossRef
|
|
[4]
|
Share of the population fully vaccinated against COVID-19. OurWorldInData.org. https://ourworldindata.org/grapher/share-people-fully-vaccinated-covid. [2021-8-12].https://ourworldindata.org/grapher/share-people-fully-vaccinated-covid |
|
[5]
|
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395(10223):470 − 3. http://dx.doi.org/10.1016/S0140-6736(20)30185-9CrossRef
|
|
[6]
|
Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med 2021;385(7):585 − 94. http://dx.doi.org/10.1056/NEJMoa2108891CrossRef
|